A clinical review: Covid19 and Dermatology

Authors : Hanife Merve AKÇA

Pages : 530-535

View : 60 | Download : 7

Publication Date : 2022-03-18

Article Type : Review Paper

Abstract :On March 11, 2020, the World Health Organizationinsert ignore into journalissuearticles values(WHO); declared Corona Virus Disease-2019insert ignore into journalissuearticles values(COVID-19); as a pandemic disease caused by SARS-CoV-2. During the COVID-19 pandemic, the importance of dermatology practice in patient management has emerged. Skin involvement was rarely documented in the first reported case series. The reason for this has been shown to be that a complete dermatological examination can not be performed in cases. Over time, significantly higher rates of skin findings have been reported.The mechanism of skin lesions associated with COVID-19 is not yet clear. The most common view is that lymphocytic vasculitis caused by vascularly located viral particles and langerhans cell activation is caused by an immune response to infection leading to vasodilation and spongiosis.Keratinocytes are thought to be secondary targets.It has been emphasized that skin findings are encountered at rates varying between 2-20% in COVID-19 patients. Casas et al. performed the first prospective study to classify the skin manifestations of COVID-19 into five major groups, including pseudo-chilblains insert ignore into journalissuearticles values(19%);, other vesicular eruptions insert ignore into journalissuearticles values(9%);,maculopapuler eruptioninsert ignore into journalissuearticles values(47%);,livedo or necrosisinsert ignore into journalissuearticles values(6%); and urticarial lesions insert ignore into journalissuearticles values(19%);.
Keywords : COVID 19, Dermatology, Cutaneous Manifestations

ORIGINAL ARTICLE URL